Skip to main content

Early Detection Research Network (EDRN)

Visit the EDRN Website

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Khasabov, Sergey G	University Of Minnesota United States	Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	5R01CA263777-05	Rachel Altshuler, Ph.D.
Kibel, Adam S	Brigham And Women'S Hospital United States	Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer	5U01CA268810-03	Guillermo Marquez, Ph.D.
Kim, Hyung L	Cedars-Sinai Medical Center United States	Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer	5R01CA280060-03	Howard L. Parnes, M.D.
Kim, Michelle Kang	Cleveland Clinic Lerner Com-Cwru United States	Assessing feasibility of gastric cancer screening in the US	1R37CA300540-01	Claire Zhu, Ph.D.
Kirkwood, Kimberly Saunders	University Of California, San Francisco United States	Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer	5U01CA282269-02	Matthew Young, Ph.D.
Kisiel, John	Mayo Clinic Rochester United States	Multi-cancer Early Detection	2R01CA214679-08	Matthew Young, Ph.D.
Kleckner, Amber Simmons	University Of Maryland Baltimore United States	Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies	5R01CA284082-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kleckner, Amber Simmons	University Of Maryland Baltimore United States	Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies	5R01CA284082-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Klein, Alison P	Johns Hopkins University United States	Improving Management of patients at High Risk of Pancreatic Cancer	1R01CA299421-01	Matthew Young, Ph.D.
Klopp, Ann	University Of Tx Md Anderson Can Ctr United States	Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer	1R01CA301124-01	Goli Samimi, Ph.D., M.P.H.
Knoerl, Robert James	University Of Michigan At Ann Arbor United States	Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.	5R34CA286712-02	Goli Samimi, Ph.D., M.P.H.
Knoerl, Robert James	University Of Michigan At Ann Arbor United States	Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.	5R34CA286712-02	Goli Samimi, Ph.D., M.P.H.
Knoerl, Robert James	University Of Michigan At Ann Arbor United States	Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.	5R34CA286712-02	Goli Samimi, Ph.D., M.P.H.
Knoerl, Robert James	University Of Michigan At Ann Arbor United States	Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.	5R34CA286712-02	Goli Samimi, Ph.D., M.P.H.
Kober, Kord Michael	University Of California, San Francisco United States	An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach	5R37CA233774-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.

News and Events